AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Journal article |
| Vydáno: |
2008
|
| _version_ | 1826296538157023232 |
|---|---|
| author | Dummer, R Robert, C Chapman, P Sosman, J Middleton, M Bastholt, L Kemsley, K Cantarini, M Morris, C Kirkwood, J |
| author_facet | Dummer, R Robert, C Chapman, P Sosman, J Middleton, M Bastholt, L Kemsley, K Cantarini, M Morris, C Kirkwood, J |
| author_sort | Dummer, R |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T04:17:53Z |
| format | Journal article |
| id | oxford-uuid:ca010e76-3d4c-4271-a50d-45c8d02d9b16 |
| institution | University of Oxford |
| last_indexed | 2024-03-07T04:17:53Z |
| publishDate | 2008 |
| record_format | dspace |
| spelling | oxford-uuid:ca010e76-3d4c-4271-a50d-45c8d02d9b162022-03-27T07:04:15ZAZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ca010e76-3d4c-4271-a50d-45c8d02d9b16Symplectic Elements at Oxford2008Dummer, RRobert, CChapman, PSosman, JMiddleton, MBastholt, LKemsley, KCantarini, MMorris, CKirkwood, J |
| spellingShingle | Dummer, R Robert, C Chapman, P Sosman, J Middleton, M Bastholt, L Kemsley, K Cantarini, M Morris, C Kirkwood, J AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study |
| title | AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study |
| title_full | AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study |
| title_fullStr | AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study |
| title_full_unstemmed | AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study |
| title_short | AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study |
| title_sort | azd6244 arry 142886 vs temozolomide tmz in patients pts with advanced melanoma an open label randomized multicenter phase ii study |
| work_keys_str_mv | AT dummerr azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy AT robertc azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy AT chapmanp azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy AT sosmanj azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy AT middletonm azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy AT bastholtl azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy AT kemsleyk azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy AT cantarinim azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy AT morrisc azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy AT kirkwoodj azd6244arry142886vstemozolomidetmzinpatientsptswithadvancedmelanomaanopenlabelrandomizedmulticenterphaseiistudy |